Your browser doesn't support javascript.
loading
PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial.
Coulibaly, Drissa; Kone, Abdoulaye K; Traore, Karim; Niangaly, Amadou; Kouriba, Bourema; Arama, Charles; Zeguime, Amatigue; Dolo, Amagana; Lyke, Kirsten E; Plowe, Christopher V; Abebe, Yonas; Potter, Gail E; Kennedy, Jessie K; Galbiati, Shirley M; Nomicos, Effie; Deye, Gregory A; Richie, Thomas L; James, Eric R; Kc, Natasha; Sim, B Kim Lee; Hoffman, Stephen L; Doumbo, Ogobara K; Thera, Mahamadou A; Laurens, Matthew B.
  • Coulibaly D; Malaria Research and Training Center, University of Sciences, Techniques and Technologies, Bamako, Mali.
  • Kone AK; Malaria Research and Training Center, University of Sciences, Techniques and Technologies, Bamako, Mali.
  • Traore K; Malaria Research and Training Center, University of Sciences, Techniques and Technologies, Bamako, Mali.
  • Niangaly A; Malaria Research and Training Center, University of Sciences, Techniques and Technologies, Bamako, Mali.
  • Kouriba B; Malaria Research and Training Center, University of Sciences, Techniques and Technologies, Bamako, Mali.
  • Arama C; Malaria Research and Training Center, University of Sciences, Techniques and Technologies, Bamako, Mali.
  • Zeguime A; Malaria Research and Training Center, University of Sciences, Techniques and Technologies, Bamako, Mali.
  • Dolo A; Malaria Research and Training Center, University of Sciences, Techniques and Technologies, Bamako, Mali.
  • Lyke KE; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Plowe CV; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Abebe Y; Sanaria, Inc, Rockville, Maryland, USA.
  • Potter GE; The Emmes Company, LLC, Rockville, MD, United States.
  • Kennedy JK; The Emmes Company, LLC, Rockville, MD, United States.
  • Galbiati SM; The Emmes Company, LLC, Rockville, MD, United States.
  • Nomicos E; Parasitic and International Programs Branch, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, U. S. National Institutes of Health, Bethesda, MD, United States.
  • Deye GA; Parasitic and International Programs Branch, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, U. S. National Institutes of Health, Bethesda, MD, United States.
  • Richie TL; Sanaria, Inc, Rockville, Maryland, USA.
  • James ER; Sanaria, Inc, Rockville, Maryland, USA.
  • Kc N; Sanaria, Inc, Rockville, Maryland, USA.
  • Sim BKL; Sanaria, Inc, Rockville, Maryland, USA.
  • Hoffman SL; Sanaria, Inc, Rockville, Maryland, USA.
  • Doumbo OK; Malaria Research and Training Center, University of Sciences, Techniques and Technologies, Bamako, Mali.
  • Thera MA; Malaria Research and Training Center, University of Sciences, Techniques and Technologies, Bamako, Mali.
  • Laurens MB; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
EClinicalMedicine ; 52: 101579, 2022 Oct.
Article en En | MEDLINE | ID: mdl-35928033
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Idioma: En Año: 2022 Tipo del documento: Article